Skip to content

Clinical trials

Cognitive Dysfunction trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Country / region: Finland Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20132
20141
20172
20183
20191
20212
20235
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status5
Recruiting4
Active, not recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Turku University Hospital3
Finnish Institute for Health and Welfare2
Novartis Pharmaceuticals2
AC Immune SA1
AbbVie1
Bristol-Myers Squibb1
Finnish Institute of Occupational Health1
GE Healthcare1
Helsinki University Central Hospital1
Imperial College London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction22
Dementia14
Alzheimer Disease12
Brain Diseases4
Memory Disorders4
Nervous System Diseases3
Neurodegenerative Diseases3
Tauopathies3
Central Nervous System Diseases2
Frontotemporal Dementia2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.